BENEVICH ERIC (Chief Commercial Officer) sold 11.7% of their position (5.97K shares) of NEUROCRINE BIOSCIENCES INC on the open market
Open‑market sale worth $905.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/2/2025ACC: 0001643653-25-000007
Officer· Chief Commercial Officer
Since Feb 2019
-5.97K
Net shares
Net seller
$905.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5.97K acquired · 11.94K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5.97K
Price / share
$35.99
Trade value
$214.86K
% of position
13.3%
11/28/2025
44.89K→50.86K
Common Stock
Direct
Shares
−5.97K
Price / share
$151.74
Trade value
$905.88K
% of position
11.7%
11/28/2025
50.86K→44.89K
Total
Net shares
+0.00
Net value
-$691.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/28/2025 | M · Option Exercise | +5.97K | $35.99 | $214.86K | 13.3% | 44.89K | 50.86K |
| Common Stock Direct | 11/28/2025 | S · Sale | −5.97K | $151.74 | $905.88K | 11.7% | 50.86K | 44.89K |
| Total | +0.00 | -$691.02K | ||||||
Derivative Transactions1
Incentive Stock Option
Direct
Converts to
Common Stock
5.97K shares
Shares
−5.97K
Strike price
35.99
Held after
6.86K
Exercisable
—
11/28/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Incentive Stock Option Direct | Common Stock5.97K shares | 11/28/2025 | M · Option Exercise | −5.97K | 35.99 | — | 6.86K |